TREX1 and autoimmune disease: However, when TREX1-mediated LINE-1 suppression was first linked to the development of autoimmune diseases, azidothymidine (AZT, an NRTI that is widely used in HIV treatment) was tested and found to not ameliorate the inflammatory symptoms detected in TREX1 knockout mice (65).